VWM
VRTX icon

Venturi Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Venturi Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Sell
3,420
-477
-12% -$211K 0.07% 149
2026
Q1 		$1.74M Sell
3,897
-1,733
-31% -$808K 0.08% 137
2025
Q4 		$2.55M Sell
5,630
-158
-3% -$68.1K 0.11% 98
2025
Q3 		$2.27M Sell
5,788
-83
-1% -$34.7K 0.11% 105
2025
Q2 		$2.61M Sell
5,871
-34
-0.6% -$15.7K 0.13% 98
2025
Q1 		$2.86M Sell
5,905
-207
-3% -$96.5K 0.15% 84
2024
Q4 		$2.46M Buy
6,112
+3,580
+141% +$1.66M 0.12% 105
2024
Q3 		$1.18M Buy
2,532
+40
+2% +$19.2K 0.06% 172
2024
Q2 		$1.17M Buy
2,492
+190
+8% +$82.5K 0.07% 163
2024
Q1 		$962K Buy
2,302
+9
+0.4% +$3.81K 0.06% 189
2023
Q4 		$933K Buy
2,293
+24
+1% +$8.87K 0.07% 181
2023
Q3 		$789K Buy
2,269
+82
+4% +$28.7K 0.06% 191
2023
Q2 		$770K Sell
2,187
-6
-0.3% -$2.02K 0.06% 186
2023
Q1 		$691K Sell
2,193
-215
-9% -$64.5K 0.06% 207
2022
Q4 		$695K Buy
2,408
+239
+11% +$72.8K 0.06% 209
2022
Q3 		$628K Buy
2,169
+207
+11% +$59.6K 0.06% 205
2022
Q2 		$553K Sell
1,962
-570
-23% -$153K 0.05% 218
2022
Q1 		$661K Buy
2,532
+782
+45% +$186K 0.05% 217
2021
Q4 		$384K Sell
1,750
-34
-2% -$6.61K 0.03% 268
2021
Q3 		$324K Buy
+1,784
New +$348K 0.03% 265
2019
Q1 		– Sell
-1,704
Closed -$279K – 272
2018
Q4 		$279K Buy
+1,704
New +$295K 0.05% 217

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Venturi Wealth Management's VRTX Position: Q2 2026 in Review

Venturi Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 12% in Q2 2026, selling an estimated $211K and leaving 3,420 shares worth $1.7M. The position accounts for 0.07% of the portfolio, ranked #149.

Venturi Wealth Management first reported a position in VRTX in Q4 2018 and has held it in 21 quarters since. The position peaked at $2.86M in Q1 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Venturi Wealth Management held 3,420 shares of Vertex Pharmaceuticals worth $1.7M as of Q2 2026.
  • Venturi Wealth Management sold 477 Vertex Pharmaceuticals shares in Q2 2026, an estimated $211K.
  • Vertex Pharmaceuticals made up 0.07% of Venturi Wealth Management's portfolio in Q2 2026, its #149 holding.
  • Venturi Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 21 quarters since.
  • Venturi Wealth Management's Vertex Pharmaceuticals position peaked at $2.86M in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.